Gastroenterology Archives

Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease (ACG)

Symposia-based education significantly improved provider knowledge, competence, and confidence for all learning domains except shared decision making and treatment selection. Based on learner data and qualitative provider feedback, a freely accessible web-based platform was launched (IBD CDST; www. CDSTforIBD.com).

Presentation Year: 2024

Presented at: American College of Gastroenterology (ACG)

Gastroenterology
Presented 2024

An Inflammatory Bowel Disease (IBD) Decision Support Tool Predicts Drug Specific Remission and Improves Provider Mastery in Treatment Selection

The CDST is unique among point-of-care tools in that it provides differential predictions for endoscopic remission with vedolizumab, adalimumab, and tofacitinib. This tool, which has the potential to improve patient outcomes, was supported and disseminated via web-based education. Findings from data collected during the 3 successive years of programming to-date revealed a significant increase in clinical mastery. Ultimately, clinicians engaged with this patient population who have participated in the education are more likely to use the tool regularly and correctly, as well as disseminating it amongst their colleagues.

Presentation Year: 2023

Presented at: Digestive Disease Week (DDW)

Gastroenterology
Presented 2023

Multi-Year Education Facilitated the Clinical Implementation of a Novel Point-of-Care Tool

The third installment of the US IBD Health Outcomes Consortium (HOC) initiative built upon insights gained from Phases I & II and was designed to empower gastroenterology clinicians to utilize the Clinical Decision Support Tool (CDST, a Web-based, interactive point-of-care tool accessible from any device, which provides guidance on optimal treatment selection based on prognostic and predictive modeling), in clinical practice. While Phases I & II focused on explanation of what the tool is and how to use it, Phase III the central goal was to enable clinicians to leverage that learning to use this novel tool in their clinical practice. Following their participation in the most recent education, 100% of gastroenterologists reported intent to use the tool (82% of whom reported they would not use the tool at Pre-Test).

Presentation Year: 2023

Presented at: American Board of Medical Specialties (ABMS)

Gastroenterology
Presented 2023

How Education Facilitated Uptake of a Novel Point of Care Decision Aid in IBD: The IBD Clinical Decision Support Tool

There has been a progressive increase in the frequency of CDST usage between October 2019 and August 2023. 30,172 patient scenarios have been input into the IBD CDST to date. Serial education facilitated the real time observation of increases in clinician empowerment via course content adapted to meet demonstrated need. In real terms, learners pivoted their demonstrated mastery (243% overall improvement in correctness and confidence in their correctness) into substantially increased usage of the tool and by extension improved clinical efficacy. As of the last survey clinicians demonstrable appreciation of the value of the tool is their organic peer to peer dissemination of the IBD CDST.

Presentation Year: 2023

Presented at: American College of Gastroenterology (ACG)

Gastroenterology
Presented 2023

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

Choosing the correct first therapy for your patients with ulcerative colitis (UC) can be tricky, but it is important because it gives them the best chance at a better life with UC. Getting it right early increases their odds of remission and reduces their risk of progression, hospitalization, and colectomy. Here are 6 ways to help get it right the first time.

Presentation Year: 2023

Gastroenterology
Presented 2023

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Over the past couple of years, several clinical decision support tools (CDSTs) have emerged to more effectively risk stratify patients and one actually predicts their response to certain biologics before they even start them.

Presentation Year: 2023

Gastroenterology
Presented 2023

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

There is considerable practice variability among providers caring for inflammatory bowel disease (IBD) patients. Limited data exists on the effectiveness of educational interventions targeting IBD providers to address these gaps. We report outcomes for a 5-year provider education training program which culminated in an enduring online education resource and clinical decision support tool.

Presentation Year: 2021

Presented at: Accreditation Countil for Continuing Medical Education (ACCME), Digestive Disease Week (DDW)

Gastroenterology
Presented 2021

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

Details Coming Soon

Presentation Year: 2021

Presented at: Accreditation Countil for Continuing Medical Education (ACCME), Digestive Disease Week (DDW)

Gastroenterology
Presented 2021

When the Patient Voice is Heard in Education, Does the Clinician Listen?

In recent years, the U.S. healthcare system has moved to adopt new models of care that focus on personalized medicine and patient centricity. It follows that the education developed for healthcare professionals must meaningfully empower them with insights for more effective patient engagement and facilitate patient activation. The challenge is, and has been, to meaningfully represent the patient “voice” or their real-world care experiences in content developed by non-patient faculty.

Presentation Year: 2019, 2020

Presented at: Accreditation Countil for Continuing Medical Education (ACCME), Alliance for Continuing Education in the Health Professions (ACEHP), Alliance Industry Summit (AIS), American Board of Medical Specialties (ABMS)

Gastroenterology, Hematology / Oncology
Presented 2019, 2020

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty

In recent years, the U.S. healthcare system has moved to adopt new models of care that focus on personalized medicine and patient-centricity. It follows that the education developed for healthcare professionals must meaningfully empower them with insights for more effective patient engagement and facilitate patient activation. The challenge is, and has been, to meaningfully represent the patient “voice”.

Presentation Year: 2019

Presented at: Crohn’s and Colitis Congress (CCC)

Gastroenterology
Presented 2019

RMEI Educational Outcomes

Provider Education and Clinical Decision Support Tool Improve Proficiency in Advanced Therapies for Inflammatory Bowel Disease (ACG)

An Inflammatory Bowel Disease (IBD) Decision Support Tool Predicts Drug Specific Remission and Improves Provider Mastery in Treatment Selection

Multi-Year Education Facilitated the Clinical Implementation of a Novel Point-of-Care Tool

How Education Facilitated Uptake of a Novel Point of Care Decision Aid in IBD: The IBD Clinical Decision Support Tool

6 Ways to Help You Choose the Right Initial Therapy for Your Patient with Ulcerative Colitis

These 3 Tools Will Change the Way You Manage IBD in Your Patients

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

Effectiveness of 5-year IBD Provider Online Educational Intervention Program

When the Patient Voice is Heard in Education, Does the Clinician Listen?

When the Patient Voice is Heard in Education, Does the Clinican Listen? Dual Track Patient/Provider Education in IBD Incorporating Patients as Learners and Faculty